Cargando…

Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementia

BACKGROUND: Agitation is a common neuropsychiatric symptom of Alzheimer disease (AD). Data are scarce regarding agitation prevalence among community‐dwelling patients with AD. OBJECTIVE: To estimate agitation prevalence in a sample of US patients with AD/dementia overall and by AD/dementia disease s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Halpern, Rachel, Seare, Jerald, Tong, Junliang, Hartry, Ann, Olaoye, Anthony, Aigbogun, Myrlene Sanon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379654/ https://www.ncbi.nlm.nih.gov/pubmed/30430642 http://dx.doi.org/10.1002/gps.5030

Ejemplares similares

Institutionalization risk and costs associated with agitation in Alzheimer's disease
por: Cloutier, Martin, et al.
Publicado: (2019)

Treatment patterns and burden of behavioral disturbances in patients with dementia in the United States: a claims database analysis
por: Aigbogun, Myrlene Sanon, et al.
Publicado: (2019)

Agitation in Dementia: Real-World Impact and Burden on Patients and the Healthcare System
por: Jones, Eddie, et al.
Publicado: (2021)

Real-World Treatment Patterns and Characteristics Among Patients with Agitation and Dementia in the United States: Findings from a Large, Observational, Retrospective Chart Review
por: Aigbogun, Myrlene Sanon, et al.
Publicado: (2020)

A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer’s Disease Patients
por: Bent-Ennakhil, Nawal, et al.
Publicado: (2017)

The Symptoms Targeted for Monitoring in a Web-Based Tracking Tool by Caregivers of People With Dementia and Agitation: Cross-Sectional Study
por: Rockwood, Kenneth, et al.
Publicado: (2019)

Impact of agitation in long‐term care residents with dementia in the United States
por: Fillit, Howard, et al.
Publicado: (2021)

The conceptual relevance of assessment measures in patients with mild/mild-moderate Alzheimer's disease
por: Hartry, Ann, et al.
Publicado: (2018)

Severity of memory impairment in the elderly: Association with health care resource use and functional limitations in the United States
por: Aigbogun, Myrlene Sanon, et al.
Publicado: (2017)

Radiographic Imaging in Autosomal Dominant Polycystic Kidney Disease: A Claims Analysis
por: Sanon Aigbogun, Myrlene, et al.
Publicado: (2021)

Association of the US Food and Drug Administration Antipsychotic Drug Boxed Warning With Medication Use and Health Outcomes in Elderly Patients With Dementia
por: Rubino, Annalisa, et al.
Publicado: (2020)

The societal economic burden of autosomal dominant polycystic kidney disease in the United States
por: Cloutier, Martin, et al.
Publicado: (2020)

Development of a Claims-Based Algorithm to Identify Patients With Agitation in Alzheimer’s Dementia
por: Hwang, Steve, et al.
Publicado: (2020)

Sequential drug treatment algorithm for agitation and aggression in Alzheimer’s and mixed dementia
por: Davies, Simon JC, et al.
Publicado: (2018)

Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia: A Randomized Clinical Trial
por: Lee, Daniel, et al.
Publicado: (2023)

Disconnect in Assessments of Autosomal Dominant Polycystic Kidney Disease Burden Between Patients and Physicians: A Survey Study
por: Sanon Aigbogun, Myrlene, et al.
Publicado: (2021)

Challenges of Agitation in Dementia: A Plea for Early Discussion
por: Richler, Leah G., et al.
Publicado: (2023)

Estimating prevalence of early symptomatic Alzheimer's disease in the United States
por: Spargo, Drew, et al.
Publicado: (2023)

Discomfort and agitation in older adults with dementia
por: Pelletier, Isabelle Chantale, et al.
Publicado: (2007)

Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial
por: Fox, Chris, et al.
Publicado: (2012)

Gabapentin in the treatment of dementia-associated nocturnal agitation
por: Buskova, Jitka, et al.
Publicado: (2011)

Stress Cardiomyopathy in Association with Severe Agitation in Dementia
por: Amin, Hina, et al.
Publicado: (2019)

ELECTROCONVULSIVE THERAPY FOR AGITATION IN LEWY BODIES DEMENTIA
por: Echeverria, C., et al.
Publicado: (2023)

REMOTE ELECTRONIC DATA CAPTURE OF MEDICATION USE AND AGITATION SYMPTOMS IN OLDER ADULTS WITH MCI OR DEMENTIA
por: Au-Yeung, Wan-Tai, et al.
Publicado: (2022)

Deuterated dextromethorphan/quinidine for agitation in Alzheimer's disease
por: Khoury, Rita
Publicado: (2021)

Effects of Music on Agitation in Dementia: A Meta-Analysis
por: Pedersen, Siv K. A., et al.
Publicado: (2017)

Evidence for using dextromethorphan-quinidine for the treatment of agitation in dementia
por: Tampi, Rajesh R, et al.
Publicado: (2020)

Management of Agitation in Dementia and Effects on Inpatient Length of Stay
por: Silverstone-Simard, Isabelle, et al.
Publicado: (2021)

A reflection on the use of Antidepressants to manage agitation in dementia
por: Basto, M.D.R.D.R.F.D., et al.
Publicado: (2022)

Agitation in Alzheimer's disease: Novel outcome measures reflecting the International Psychogeriatric Association (IPA) agitation criteria
por: De Mauleon, Adelaide, et al.
Publicado: (2021)

Agitation in Dementia: Relation to Core Cerebrospinal Fluid Biomarker Levels
por: Bloniecki, Victor, et al.
Publicado: (2014)

Measuring Electrodermal Activity to Improve the Identification of Agitation in Individuals with Dementia
por: Melander, Catharina, et al.
Publicado: (2017)

Agitation near the end of life with dementia: An ethnographic study of care
por: Sampson, Elizabeth L., et al.
Publicado: (2019)

Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions
por: Carrarini, Claudia, et al.
Publicado: (2021)

The Impact of Agitation in Dementia on Caregivers: A Real-World Survey
por: Schein, Jeff, et al.
Publicado: (2022)

Toward Quantification of Agitation in People With Dementia Using Multimodal Sensing
por: Davidoff, Hannah, et al.
Publicado: (2022)

Similarities and differences in Alzheimer’s dementia comorbidities in racialized populations identified from electronic medical records
por: Woldemariam, Sarah R., et al.
Publicado: (2023)

REJECTION OF CARE, AGGRESSION, AND AGITATION IN PERSONS WITH DEMENTIA: A REVIEW OF DEFINITIONS IN DEMENTIA MEASURES
por: Choi, Scott, et al.
Publicado: (2019)

Healthcare resource utilisation and costs of agitation in people with dementia living in care homes in England - The Managing Agitation and Raising QUality of LifE in Dementia (MARQUE) study
por: Panca, Monica, et al.
Publicado: (2019)

Patient and Care Partner Burden in CKD Patients With and Without Anemia: A US-Based Survey
por: Michalopoulos, Steven N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e6m5kfif1ore03fnah9ni2osim